Literature DB >> 28025810

Application of a Combined Approach to Identify New Psychoactive Street Drugs and Decipher Their Mechanisms at Monoamine Transporters.

Felix P Mayer1, Anton Luf2, Constanze Nagy3, Marion Holy1, Rainer Schmid2, Michael Freissmuth1, Harald H Sitte4,5.   

Abstract

Psychoactive compounds can cause acute and long-term health problems and lead to addiction. In addition to well-studied and legally controlled compounds like cocaine, new psychoactive substances (NPS) are appearing in street drug markets as replacement strategies and legal alternatives. NPS are effectively marketed as "designer drugs" or "research chemicals" without any knowledge of their underlying pharmacological mode of action and their potential toxicological effects and obviously devoid of any registration process. As of 2016, the knowledge of structure-activity relationships for most NPS is scarce, and predicting detailed pharmacological activity of newly emerging drugs is a challenging task. Therefore, it is important to combine different approaches and employ biological test systems that are superior to mere chemical analysis in recognizing novel and potentially harmful street drugs. In this chapter, we provide a detailed description of techniques to decipher the molecular mechanism of action of NPS that target the high-affinity transporters for dopamine, norepinephrine, and serotonin. In addition, this chapter provides insights into a combined approach to identify and characterize new psychoactive street drugs of unknown content in a collaboration with the Austrian prevention project "checkit!."

Entities:  

Keywords:  Amphetamine; Analytical identification; Bath salts; Cocaine; Dopamine; Monoamine transporters; New psychoactive substances; Norepinephrine; Psychostimulants; Research chemicals; Serotonin

Mesh:

Substances:

Year:  2017        PMID: 28025810     DOI: 10.1007/7854_2016_63

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  10 in total

1.  (2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice.

Authors:  Deborah Rudin; John D McCorvy; Grant C Glatfelter; Dino Luethi; Dániel Szöllősi; Tea Ljubišić; Pierce V Kavanagh; Geraldine Dowling; Marion Holy; Kathrin Jaentsch; Donna Walther; Simon D Brandt; Thomas Stockner; Michael H Baumann; Adam L Halberstadt; Harald H Sitte
Journal:  Neuropsychopharmacology       Date:  2021-11-08       Impact factor: 8.294

2.  Effects of Hydroxylated Mephedrone Metabolites on Monoamine Transporter Activity in vitro.

Authors:  Marco Niello; Daniela Cintulová; Philip Raithmayr; Marion Holy; Kathrin Jäntsch; Claire Colas; Gerhard F Ecker; Harald H Sitte; Marko D Mihovilovic
Journal:  Front Pharmacol       Date:  2021-04-09       Impact factor: 5.988

3.  Comparative analysis of novel decynium-22 analogs to inhibit transport by the low-affinity, high-capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter.

Authors:  Rheaclare Fraser-Spears; Anwen M Krause-Heuer; Mohamed Basiouny; Felix P Mayer; Retrouvailles Manishimwe; Naomi A Wyatt; Jeremy C Dobrowolski; Maxine P Roberts; Ivan Greguric; Naresh Kumar; Wouter Koek; Harald H Sitte; Paul D Callaghan; Benjamin H Fraser; Lynette C Daws
Journal:  Eur J Pharmacol       Date:  2018-10-25       Impact factor: 5.195

4.  A kinetic account for amphetamine-induced monoamine release.

Authors:  Peter S Hasenhuetl; Shreyas Bhat; Felix P Mayer; Harald H Sitte; Michael Freissmuth; Walter Sandtner
Journal:  J Gen Physiol       Date:  2018-02-09       Impact factor: 4.086

5.  Cell-Based Radiotracer Binding and Uptake Inhibition Assays: A Comparison of In Vitro Methods to Assess the Potency of Drugs That Target Monoamine Transporters.

Authors:  Marija Ilic; Marion Holy; Kathrin Jaentsch; Matthias E Liechti; Gert Lubec; Michael H Baumann; Harald H Sitte; Dino Luethi
Journal:  Front Pharmacol       Date:  2020-05-19       Impact factor: 5.810

6.  Neuropsychopharmacology of Emerging Drugs of Abuse: meta- and para-Halogen-Ring-Substituted α-PVP ("flakka") Derivatives.

Authors:  Núria Nadal-Gratacós; Esther Lleixà; Mónica Gibert-Serramià; Roger Estrada-Tejedor; Xavier Berzosa; Xavier Batllori; David Pubill; Jordi Camarasa; Elena Escubedo; Raúl López-Arnau
Journal:  Int J Mol Sci       Date:  2022-02-17       Impact factor: 5.923

7.  Fluorinated phenmetrazine "legal highs" act as substrates for high-affinity monoamine transporters of the SLC6 family.

Authors:  Felix P Mayer; Nadine V Burchardt; Ann M Decker; John S Partilla; Yang Li; Gavin McLaughlin; Pierce V Kavanagh; Walter Sandtner; Bruce E Blough; Simon D Brandt; Michael H Baumann; Harald H Sitte
Journal:  Neuropharmacology       Date:  2017-10-06       Impact factor: 5.273

8.  An unsuspected role for organic cation transporter 3 in the actions of amphetamine.

Authors:  Felix P Mayer; Diethart Schmid; W Anthony Owens; Georgianna G Gould; Mia Apuschkin; Oliver Kudlacek; Isabella Salzer; Stefan Boehm; Peter Chiba; Piper H Williams; Hsiao-Huei Wu; Ulrik Gether; Wouter Koek; Lynette C Daws; Harald H Sitte
Journal:  Neuropsychopharmacology       Date:  2018-04-06       Impact factor: 8.294

9.  [Comorbidity of posttraumatic stress disorder and addiction from a biopsychosocial perspective].

Authors:  Hans-Peter Kapfhammer
Journal:  Neuropsychiatr       Date:  2021-01-13

Review 10.  SLC6 transporter oligomerization.

Authors:  Kumaresan Jayaraman; Anand K Das; Dino Luethi; Dániel Szöllősi; Gerhard J Schütz; Maarten E A Reith; Harald H Sitte; Thomas Stockner
Journal:  J Neurochem       Date:  2020-08-28       Impact factor: 5.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.